▶ 調査レポート

世界のグラム陽性菌感染症治療薬市場：市場規模・現状・予測
• 英文タイトル：Global Gram-positive Bacterial Infection Drugs Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界のグラム陽性菌感染症治療薬市場：市場規模・現状・予測 / Global Gram-positive Bacterial Infection Drugs Market Size, Status and Forecast 2019-2025 / QYR9N7257資料のイメージです。• レポートコード：QYR9N7257
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、グラム陽性菌感染症治療薬のグローバル市場について調査・分析したレポートで、種類別（抗生物質、抗真菌、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・グラム陽性菌感染症治療薬の世界市場規模
・主要企業別市場シェア
・グラム陽性菌感染症治療薬の世界市場規模：種類別（抗生物質、抗真菌、その他）
・グラム陽性菌感染症治療薬の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局）
・グラム陽性菌感染症治療薬のアメリカ市場規模（種類別、用途別）
・グラム陽性菌感染症治療薬のヨーロッパ市場規模（種類別、用途別）
・グラム陽性菌感染症治療薬の中国市場規模（種類別、用途別）
・グラム陽性菌感染症治療薬の日本市場規模（種類別、用途別）
・グラム陽性菌感染症治療薬の東南アジア市場規模（種類別、用途別）
・グラム陽性菌感染症治療薬のインド市場規模（種類別、用途別）
・グラム陽性菌感染症治療薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・グラム陽性菌感染症治療薬の世界市場予測（2019年-2025年）
・グラム陽性菌感染症治療薬の地域別市場予測（2019年-2025年）
...

Gram-positive bacteria are those that are stained dark blue or violet by Gram staining. They are a major class of bacteria that cause various infections in humans.In 2018, the global Gram-positive Bacterial Infection Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gram-positive Bacterial Infection Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gram-positive Bacterial Infection Drugs development in United States, Europe and China.

The key players covered in this study
Pfizer
Sanofi
GlaxoSmithKline
Bayer
Bristol-Myers Squibb
Novartis
Merck
AstraZeneca
Allergan
Theravance Biopharma

Market segment by Type, the product can be split into
Antibiotic
Antifungal
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gram-positive Bacterial Infection Drugs status, future forecast, growth opportunity, key market and key players.
To present the Gram-positive Bacterial Infection Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gram-positive Bacterial Infection Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gram-positive Bacterial Infection Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Antibiotic
1.4.3 Antifungal
1.4.4 Others
1.5 Market by Application
1.5.1 Global Gram-positive Bacterial Infection Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gram-positive Bacterial Infection Drugs Market Size
2.2 Gram-positive Bacterial Infection Drugs Growth Trends by Regions
2.2.1 Gram-positive Bacterial Infection Drugs Market Size by Regions (2014-2025)
2.2.2 Gram-positive Bacterial Infection Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gram-positive Bacterial Infection Drugs Market Size by Manufacturers
3.1.1 Global Gram-positive Bacterial Infection Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gram-positive Bacterial Infection Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Gram-positive Bacterial Infection Drugs Key Players Head office and Area Served
3.3 Key Players Gram-positive Bacterial Infection Drugs Product/Solution/Service
3.4 Date of Enter into Gram-positive Bacterial Infection Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gram-positive Bacterial Infection Drugs Market Size by Type (2014-2019)
4.2 Global Gram-positive Bacterial Infection Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Gram-positive Bacterial Infection Drugs Market Size (2014-2019)
5.2 Gram-positive Bacterial Infection Drugs Key Players in United States
5.3 United States Gram-positive Bacterial Infection Drugs Market Size by Type
5.4 United States Gram-positive Bacterial Infection Drugs Market Size by Application

6 Europe
6.1 Europe Gram-positive Bacterial Infection Drugs Market Size (2014-2019)
6.2 Gram-positive Bacterial Infection Drugs Key Players in Europe
6.3 Europe Gram-positive Bacterial Infection Drugs Market Size by Type
6.4 Europe Gram-positive Bacterial Infection Drugs Market Size by Application

7 China
7.1 China Gram-positive Bacterial Infection Drugs Market Size (2014-2019)
7.2 Gram-positive Bacterial Infection Drugs Key Players in China
7.3 China Gram-positive Bacterial Infection Drugs Market Size by Type
7.4 China Gram-positive Bacterial Infection Drugs Market Size by Application

8 Japan
8.1 Japan Gram-positive Bacterial Infection Drugs Market Size (2014-2019)
8.2 Gram-positive Bacterial Infection Drugs Key Players in Japan
8.3 Japan Gram-positive Bacterial Infection Drugs Market Size by Type
8.4 Japan Gram-positive Bacterial Infection Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gram-positive Bacterial Infection Drugs Market Size (2014-2019)
9.2 Gram-positive Bacterial Infection Drugs Key Players in Southeast Asia
9.3 Southeast Asia Gram-positive Bacterial Infection Drugs Market Size by Type
9.4 Southeast Asia Gram-positive Bacterial Infection Drugs Market Size by Application

10 India
10.1 India Gram-positive Bacterial Infection Drugs Market Size (2014-2019)
10.2 Gram-positive Bacterial Infection Drugs Key Players in India
10.3 India Gram-positive Bacterial Infection Drugs Market Size by Type
10.4 India Gram-positive Bacterial Infection Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Gram-positive Bacterial Infection Drugs Market Size (2014-2019)
11.2 Gram-positive Bacterial Infection Drugs Key Players in Central & South America
11.3 Central & South America Gram-positive Bacterial Infection Drugs Market Size by Type
11.4 Central & South America Gram-positive Bacterial Infection Drugs Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gram-positive Bacterial Infection Drugs Introduction
12.1.4 Pfizer Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Sanofi
12.2.1 Sanofi Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gram-positive Bacterial Infection Drugs Introduction
12.2.4 Sanofi Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)
12.2.5 Sanofi Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gram-positive Bacterial Infection Drugs Introduction
12.3.4 GlaxoSmithKline Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Bayer
12.4.1 Bayer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gram-positive Bacterial Infection Drugs Introduction
12.4.4 Bayer Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)
12.4.5 Bayer Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gram-positive Bacterial Infection Drugs Introduction
12.5.4 Bristol-Myers Squibb Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gram-positive Bacterial Infection Drugs Introduction
12.6.4 Novartis Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)
12.6.5 Novartis Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gram-positive Bacterial Infection Drugs Introduction
12.7.4 Merck Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)
12.7.5 Merck Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gram-positive Bacterial Infection Drugs Introduction
12.8.4 AstraZeneca Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)
12.8.5 AstraZeneca Recent Development
12.9 Allergan
12.9.1 Allergan Company Details
12.9.2 Company Description and Business Overview
12.9.3 Gram-positive Bacterial Infection Drugs Introduction
12.9.4 Allergan Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)
12.9.5 Allergan Recent Development
12.10 Theravance Biopharma
12.10.1 Theravance Biopharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Gram-positive Bacterial Infection Drugs Introduction
12.10.4 Theravance Biopharma Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)
12.10.5 Theravance Biopharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Gram-positive Bacterial Infection Drugs Key Market Segments
Table Key Players Gram-positive Bacterial Infection Drugs Covered
Table Global Gram-positive Bacterial Infection Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gram-positive Bacterial Infection Drugs Market Size Market Share by Type 2014-2025
Figure Antibiotic Figures
Table Key Players of Antibiotic
Figure Antifungal Figures
Table Key Players of Antifungal
Figure Others Figures
Table Key Players of Others
Table Global Gram-positive Bacterial Infection Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Gram-positive Bacterial Infection Drugs Report Years Considered
Table Global Gram-positive Bacterial Infection Drugs Market Size 2014-2025 (Million US$)
Figure Global Gram-positive Bacterial Infection Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gram-positive Bacterial Infection Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Gram-positive Bacterial Infection Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Gram-positive Bacterial Infection Drugs Market Share by Regions 2014-2019
Figure Global Gram-positive Bacterial Infection Drugs Market Share by Regions 2014-2019
Figure Global Gram-positive Bacterial Infection Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Gram-positive Bacterial Infection Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gram-positive Bacterial Infection Drugs Market Share by Manufacturers (2014-2019)
Figure Global Gram-positive Bacterial Infection Drugs Market Share by Manufacturers in 2018
Table Global Gram-positive Bacterial Infection Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gram-positive Bacterial Infection Drugs Product/Solution/Service
Table Date of Enter into Gram-positive Bacterial Infection Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gram-positive Bacterial Infection Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Gram-positive Bacterial Infection Drugs Market Size Share by Type (2014-2019)
Figure Global Gram-positive Bacterial Infection Drugs Market Size Market Share by Type (2014-2019)
Table Global Gram-positive Bacterial Infection Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Gram-positive Bacterial Infection Drugs Market Size Share by Application (2014-2019)
Figure Global Gram-positive Bacterial Infection Drugs Market Size Market Share by Application (2014-2019)
Figure Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Application in 2018
Figure United States Gram-positive Bacterial Infection Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Gram-positive Bacterial Infection Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Gram-positive Bacterial Infection Drugs Market Share (2018-2019)
Table United States Gram-positive Bacterial Infection Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Gram-positive Bacterial Infection Drugs Market Share by Type (2014-2019)
Table United States Gram-positive Bacterial Infection Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Gram-positive Bacterial Infection Drugs Market Share by Application (2014-2019)
Figure Europe Gram-positive Bacterial Infection Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Gram-positive Bacterial Infection Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Gram-positive Bacterial Infection Drugs Market Share (2018-2019)
Table Europe Gram-positive Bacterial Infection Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Gram-positive Bacterial Infection Drugs Market Share by Type (2014-2019)
Table Europe Gram-positive Bacterial Infection Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Gram-positive Bacterial Infection Drugs Market Share by Application (2014-2019)
Figure China Gram-positive Bacterial Infection Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Gram-positive Bacterial Infection Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Gram-positive Bacterial Infection Drugs Market Share (2018-2019)
Table China Gram-positive Bacterial Infection Drugs Market Size by Type (2014-20189) (Million US$)
Table China Gram-positive Bacterial Infection Drugs Market Share by Type (2014-2019)
Table China Gram-positive Bacterial Infection Drugs Market Size by Application (2014-2019) (Million US$)
Table China Gram-positive Bacterial Infection Drugs Market Share by Application (2014-2019)
Figure Japan Gram-positive Bacterial Infection Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Gram-positive Bacterial Infection Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Gram-positive Bacterial Infection Drugs Market Share (2018-2019)
Table Japan Gram-positive Bacterial Infection Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Gram-positive Bacterial Infection Drugs Market Share by Type (2014-2019)
Table Japan Gram-positive Bacterial Infection Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Gram-positive Bacterial Infection Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Gram-positive Bacterial Infection Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gram-positive Bacterial Infection Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gram-positive Bacterial Infection Drugs Market Share (2018-2019)
Table Southeast Asia Gram-positive Bacterial Infection Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gram-positive Bacterial Infection Drugs Market Share by Type (2014-2019)
Table Southeast Asia Gram-positive Bacterial Infection Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gram-positive Bacterial Infection Drugs Market Share by Application (2014-2019)
Figure India Gram-positive Bacterial Infection Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Gram-positive Bacterial Infection Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Gram-positive Bacterial Infection Drugs Market Share (2018-2019)
Table India Gram-positive Bacterial Infection Drugs Market Size by Type (2014-2019) (Million US$)
Table India Gram-positive Bacterial Infection Drugs Market Share by Type (2014-2019)
Table India Gram-positive Bacterial Infection Drugs Market Size by Application (2014-2019) (Million US$)
Table India Gram-positive Bacterial Infection Drugs Market Share by Application (2014-2019)
Figure Central & South America Gram-positive Bacterial Infection Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gram-positive Bacterial Infection Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gram-positive Bacterial Infection Drugs Market Share (2018-2019)
Table Central & South America Gram-positive Bacterial Infection Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gram-positive Bacterial Infection Drugs Market Share by Type (2014-2019)
Table Central & South America Gram-positive Bacterial Infection Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gram-positive Bacterial Infection Drugs Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2014-2019)
Table Sanofi Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Bayer Company Details
Table Bayer Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2014-2019)
Table Bayer Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Novartis Company Details
Table Novartis Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2014-2019)
Table Merck Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Allergan Company Details
Table Allergan Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2014-2019)
Table Allergan Recent Development
Table Theravance Biopharma Company Details
Table Theravance Biopharma Revenue in Gram-positive Bacterial Infection Drugs Business (2014-2019)(Million US$)
Figure Theravance Biopharma Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2014-2019)
Table Theravance Biopharma Recent Development
Table Global Gram-positive Bacterial Infection Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Gram-positive Bacterial Infection Drugs Market Size Share by Regions (2019-2025)
Figure Global Gram-positive Bacterial Infection Drugs Market Size Share by Regions in 2025
Figure United States Gram-positive Bacterial Infection Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gram-positive Bacterial Infection Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Gram-positive Bacterial Infection Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gram-positive Bacterial Infection Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gram-positive Bacterial Infection Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Gram-positive Bacterial Infection Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gram-positive Bacterial Infection Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Gram-positive Bacterial Infection Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Gram-positive Bacterial Infection Drugs Market Size by Product (2019-2025)
Figure Global Gram-positive Bacterial Infection Drugs Market Size by Product in 2025
Table Global Gram-positive Bacterial Infection Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Gram-positive Bacterial Infection Drugs Market Size by Application (2019-2025)
Figure Global Gram-positive Bacterial Infection Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の水痘帯状疱疹感染症治療薬市場2019
    Global Varicella Zoster Infection Treatment Drugs Sales Market Report 2019
    QYR9N5453 2019年6月14日 107Pages
    本調査レポートでは、水痘帯状疱疹感染症治療薬の世界市場について調査・分析し、水痘帯状疱疹感染症治療薬のメーカー別販売量、市場シェア分析、種類別販売分析（アシクロビル、バラシクロビル、ファムシクロビル、その他）、用途別販売分析（病院薬局、小売薬局、オンライン薬局）、地域別販売分析（米国、ヨーロッパ、中...
  • 世界のグラム染色市場：市場規模・現状・予測
    Global Gram Staining Market Size, Status and Forecast 2019-2025
    QYR9N7256 2019年6月14日 95Pages
    当資料は、グラム染色のグローバル市場について調査・分析したレポートで、種類別（自動グラム染色システム、キットと試薬）、用途別（病院、診断研究所、受託研究機関、学術機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界の下気道感染症の治療市場：市場規模・現状・予測
    Global Lower Respiratory Tract Infection Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7478 2019年6月14日 96Pages
    当資料は、下気道感染症の治療のグローバル市場について調査・分析したレポートで、種類別（支持療法、病院ケア、薬物、ワクチン）、用途別（病院、診療所、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のサイトメガロウイルス感染市場：市場規模・現状・予測
    Global Cytomegalovirus Infection Market Size, Status and Forecast 2019-2025
    QYR9N7059 2019年6月14日 93Pages
    当資料は、サイトメガロウイルス感染のグローバル市場について調査・分析したレポートで、種類別（シドフォビル、フォスカーネット、バルガンシクロビル、ガンシクロビル）、用途別（病院、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、...
  • 世界の歯科感染症治療市場：市場規模・現状・予測
    Global Dental Infection Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7083 2019年6月14日 97Pages
    当資料は、歯科感染症治療のグローバル市場について調査・分析したレポートで、種類別（根尖周囲膿瘍、歯周膿瘍、その他）、用途別（歯科医院、病院、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の院内感染診断市場：市場規模・現状・予測
    Global Hospital-acquired Infection Diagnostics Market Size, Status and Forecast 2019-2025
    QYR9N7315 2019年6月14日 98Pages
    当資料は、院内感染診断のグローバル市場について調査・分析したレポートで、種類別（機器と試薬、消耗品）、用途別（病院、診療所、外来手術センター（ASC）、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の唾液腺感染市場：市場規模・現状・予測
    Global Salivary Gland Infection Market Size, Status and Forecast 2019-2025
    QYR9N7991 2019年6月14日 94Pages
    当資料は、唾液腺感染のグローバル市場について調査・分析したレポートで、種類別（診断、治療）、用途別（病院、診療所、家庭、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・唾液腺感染...
  • 世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測
    Global Myelodysplastic Syndrome (MDS) Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7611 2019年6月14日 96Pages
    当資料は、骨髄異形成症候群（MDS）薬のグローバル市場について調査・分析したレポートで、種類別（低メチル化剤、免疫調節薬、抗貧血薬）、用途別（オリジナル、ジェネリック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界の非カタプレキシーナルコレプシー薬市場：市場規模・現状・予測
    Global Non Cataplexy Narcolepsy Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7681 2019年6月14日 93Pages
    当資料は、非カタプレキシーナルコレプシー薬のグローバル市場について調査・分析したレポートで、種類別（抗酸化薬、覚せい剤、その他）、用途別（子供（18歳未満）、成人（18〜50歳）、高齢者（50歳以上）、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測...
  • 世界の凍結乾燥注射薬市場：市場規模・現状・予測
    Global Lyophilized Injectable Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7487 2019年6月14日 96Pages
    当資料は、凍結乾燥注射薬のグローバル市場について調査・分析したレポートで、種類別（使い捨てバイアル、ポイントオブケア再構成、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の水痘帯状疱疹感染症治療薬市場2019世界の水痘帯状疱疹感染症治療薬市場2019 The global Varicella Zoster Infection Treatment Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Varicella Zoster Infection Treatment Drugs market status and forecast, categorizes the g…
  • 世界のサイトメガロウイルス感染市場：市場規模・現状・予測世界のサイトメガロウイルス感染市場：市場規模・現状・予測 Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection c…
  • 世界の炎症性皮膚疾患薬市場：市場規模・現状・予測世界の炎症性皮膚疾患薬市場：市場規模・現状・予測 In 2018, the global Inflammatory Skin Diseases Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Inflammatory Skin Diseases Drugs status, future forecast, growth opportunity, key …
  • 世界の神経因性疼痛治療薬市場：市場規模・現状・予測世界の神経因性疼痛治療薬市場：市場規模・現状・予測 Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia).In terms of value, North America is a large market and is expected to …
  • 世界の一般的な腫瘍治療薬市場：市場規模・現状・予測世界の一般的な腫瘍治療薬市場：市場規模・現状・予測 In 2018, the global Generic Oncology Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Generic Oncology Drugs status, future forecast, growth opportunity, key market and key playe…